Tag archive for: price

For the second year the Agnes McLaren Association is organizing a medical award worth €4,000! Applications are open to students at the Montpellier-Nîmes Faculty of Medicine who will be defending their thesis between September 2021 and March 2023. See below for registration details and thesis eligibility criteria.

 

This prize rewards a thesis in medicine focusing on the health of women and/or children in precarious or vulnerable situations and funds work based on this thesis.

TheAgnes McLaren Association, founded in 2018, works to preserve the memory ofAgnes McLaren, a Scottish woman and the first female doctor to graduate from the Faculty of Medicine in Montpellier in 1878. It is in honor of this female doctor, who dedicated her life to caring for the most disadvantaged women or those excluded from society, that the association wishes to award a medical prize for the first time.

Thus, to mark the faculty's 800th anniversary in 2020, the association established the Agnès McLaren Prize for Medicine. Every two years, this prize rewards a practical thesis and a post-thesis work (or project), focusing on the health of women in precarious/vulnerable situations or the health of children exposed to precariousness and/or vulnerable situations. It also funds a work based on this thesis. The Prize, worth €4,000, will be awarded in June 2023 after pre-selection by a committee and review by a jury composed of healthcare professionals.

For the first edition, a prize was awarded to Justine Allouche for her knowledge and practice of cervical cancer screening.

In 2021, the prize was won by Justine Allouche for her work focusing on assessing knowledge and practices regarding cervical cancer screening among women in prostitution in the Gard and Hérault departments. Justine was featured in an article in Midi Libre on this occasion!

 

 

Eligibility criteria

In order to compete for this medical award, candidates must meet several eligibility criteria:

 

  • Open to our students

    Criterion 1: Be a student at the Montpellier-Nîmes Faculty of Medicine

  • Year 2021-22-23

    Criterion 2: Defend your thesis between September 2021 and March 2023

  • Thesis topic

    Criterion 3: Defend a thesis on a topic related to the health of the most disadvantaged or even excluded women, or on the health of children exposed to precariousness and/or situations of vulnerability.

  • Post-doctoral project

    Criterion 4: Thesis leading to an operational project

What are the steps to follow to enter the competition?

The second edition of the McLaren Medical Prize will take place in five phases, as follows:

  • before March 15, 2023

  • Pre-selection phase

    Pre-selection phase of theses received by the pre-selection committee. Five theses pre-selected.

    April 15, 2023

  • May 15, 2023

    Selection notice

    Notification of selection sent to the five successful candidates.

  • Final selection phase

    Review of the five theses pre-selected by the jury. Candidates must submit their theses and post-thesis work by January 24, 2021.

    June 2023

  • Sept. 2023

    Award ceremony

    Presentation of the Agnes McLaren Award during the official ceremony.

We hope many of you will compete for this new prize! So get writing, and good luck with your theses!

 

 

On Thursday, January 27, 2022, Dr. Catherine Alix-Panabières received the prestigious Savchuk Prize at the 15th Cancer Research Biennial for her work on "liquid biopsies." A look back at 23 years of research in the field of cancer research.

A career focused on the development of liquid biopsy

Dr. Alix-Panabières, director of the Rare Human Circulating Cells (CCRH) laboratory at Montpellier University Hospital, has been dedicated to her research for 23 years. Invented by her in 2010 with her German colleague, Professor Klaus Pantel from Hamburg, the term "liquid biopsy," which complements tissue biopsy, refers to a blood test that is performed repeatedly during a patient's treatment.

 

A non-invasive procedure

Liquid biopsy provides access to circulating cells or elements that are released by the primary tumor or metastases. The advantage? It offers the possibility of studying tumors located in inaccessible areas, repeatedly and non-invasively. After taking a blood sample, this procedure provides information on the progression of the tumor and therefore on the treatment.

His research focuses on three fundamental aspects:

  1. Understanding the biology of the tumor and its destination.
  2. Technology: Dr. Alix-Panabières is working on a patent focused on this new technique for detecting circulating tumor cells.
  3. A translational clinical study. Liquid biopsy allows treatment to be tailored to each patient's stage, particularly when starting treatment.

We extend our warmest congratulations to Dr. Catherine Alix-Pananières on receiving this award!